Latest Breaking News On - Institutional investors weigh in on regeneron pharmaceuticals - Page 1 : comparemela.com

Regeneron Pharmaceuticals (NASDAQ:REGN) Earns Outperform Rating from Analysts at Evercore ISI

Regeneron Pharmaceuticals (NASDAQ:REGN) Earns Outperform Rating from Analysts at Evercore ISI
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Leonards schleiferSanfordc bernsteinArthurf ryanRegeneron pharmaceuticals incCantor fitzgeraldAnnis gardner whiting capital advisorsRegeneron pharmaceuticalsAnalyst recommendations for regeneron pharmaceuticalsCrewe advisorsFortitude family officeSecurities exchange commissionNews ratings for regeneron pharmaceuticals dailyInstitutional investors weigh in on regeneron pharmaceuticalsPaces advisors incRegeneron pharmaceuticals price performanceFree report

Regeneron Pharmaceuticals (NASDAQ:REGN) Cut to Buy at StockNews com

Regeneron Pharmaceuticals (NASDAQ:REGN) Cut to Buy at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesMarion mccourtAndrewj murphyTrinitypoint wealthCantor fitzgeraldCapital management incRegeneron pharmaceuticals incWealth managementRoyal bankSecurities exchange commissionNews ratings for regeneron pharmaceuticals dailyInstitutional investors weigh in on regeneron pharmaceuticalsRegeneron pharmaceuticalsRegeneron pharmaceuticals stockEudaimonia advisorsAnalyst recommendations for regeneron pharmaceuticals

Regeneron Pharmaceuticals (NASDAQ:REGN) Shares Down 2 6%

Regeneron Pharmaceuticals (NASDAQ:REGN) Shares Down 2 6%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Arthurf ryanAndrewj murphyRegeneron pharmaceuticalsRegeneron pharmaceuticals company profileInternational assets investment managementNews ratings for regeneron pharmaceuticals dailyRegeneron pharmaceuticals incNorges bankMoneta group investment advisorsRoyal bankInstitutional investors weigh in on regeneron pharmaceuticalsFirst trust advisorsSecurities exchange commissionRegeneron pharmaceuticals price performanceCantor fitzgeraldGet free report

Regeneron Pharmaceuticals (REGN) Buy Rating Reaffirmed at Truist Financial

Truist Financial reissued their buy rating on shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Truist Financial currently has a $1,135.00 price target on the biopharmaceutical company’s stock. REGN has been the subject of a number of other reports. Cantor Fitzgerald raised their price […]

Kapitalo investimentos ltdaJosephl goldsteinSanfordc bernsteinAndrewj murphyB riley wealth advisors incAnalyst recommendations for regeneron pharmaceuticalsAccent capital managementMorgan stanleyInstitutional investors weigh in on regeneron pharmaceuticalsSecurities exchange commissionNews ratings for regeneron pharmaceuticals dailyHighpoint advisor groupRegeneron pharmaceuticals incInsider transactions at regeneron pharmaceuticalsRegeneron pharmaceuticals stock performanceCantor fitzgerald

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Receives $939 05 Average PT from Analysts

Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Receives $939 05 Average PT from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Arthurf ryanBonniel basslerSecurities exchange commissionMonetary management group incStifel financial corpRegeneron pharmaceuticals incRegeneron pharmaceuticalsRegeneron pharmaceuticals stockMeyer handelman coAnalyst recommendations for regeneron pharmaceuticalsMorgan stanleyInstitutional investors weigh in on regeneron pharmaceuticalsJefferies financial groupRoyal bankCavalier investmentsNews ratings for regeneron pharmaceuticals daily